Therapeutic implications of the TLR and VDR partnership

Trends in Molecular Medicine

Volumn 13, Issue 3, 2007, Pages 117-124

  Liu, Philip T ^a   Krutzik, Stephan R ^a   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL; CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOLOGICAL ADJUVANT; LOXORIBINE; PATTERN RECOGNITION RECEPTOR; RESISQUIMOD; RETINOIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANTIMICROBIAL ACTIVITY; BACTERIUM; CONDYLOMA; FUNGUS; GENE INDUCTION; GENETIC CONSERVATION; GENITAL HERPES; HEPATITIS B; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MULTIGENE FAMILY; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA; NONHUMAN; RECEPTOR UPREGULATION; REVIEW; SYSTEMATIC REVIEW; VIRUS; VIRUS GENE;

ANIMALS; CHOLECALCIFEROL; HUMANS; IMMUNITY, NATURAL; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CALCITRIOL; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS;

FUNGI; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA;

EID: 33847381996     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2007.01.006     Document Type: Review

References (71)

1. Hasan U., et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 174 (2005) 2942-2950
2. Zhang D., et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303 (2004) 1522-1526
3. Yarovinsky F., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308 (2005) 1626-1629
4. Krutzik S.R., et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11 (2005) 653-660
5. Modlin R.L., and Cheng G. From plankton to pathogen recognition. Nat. Med. 10 (2004) 1173-1174
6. Hertz C.J., et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human β defensin-2. J. Immunol. 171 (2003) 6820-6826
7. Hertz C.J., et al. Microbial lipopeptides stimulate dendritic cell maturation via TLR2. J. Immunol. 166 (2000) 2444-2450
8. Liu P.T., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
9. Doyle S., et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17 (2002) 251-253
10. Kaisho T., and Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117 (2006) 979-987
11. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18 (2006) 3-9
12. Brightbill H.D., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
13. Doyle S.E., et al. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199 (2004) 81-90
14. Thoma-Uszynski S., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291 (2001) 1544-1547
15. Arruda L.B., et al. Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes. J. Immunol. 177 (2006) 2265-2275
16. Hemmi H., et al. The roles of toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170 (2003) 3059-3064
17. Takeda K., et al. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. 8 (2002) 459-463
18. Kawase T., et al. Up-regulation of inducible nitric oxide (NO) synthase and NO production in HL-60 cells stimulated to differentiate by phorbol 12-myristate 13-acetate plus 1,25-dihydroxyvitamin D3 is not obtained with dimethylsulfoxide plus 1,25-dihydroxyvitamin D3. Calcif. Tissue Int. 63 (1998) 27-35
19. Durr U.H., et al. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 1758 (2006) 1408-1425
20. Chang J.M., et al. 1-α,25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J. Lab. Clin. Med. 143 (2004) 14-22
21. Pivarcsi A., et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells. Microbes Infect. 7 (2005) 1117-1127
22. Pedersen G., et al. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Clin. Exp. Immunol. 141 (2005) 298-306
23. Cario E., et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J. Immunol. 164 (2000) 966-972
24. Kumar A., et al. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology 117 (2006) 11-21
25. Rhee S.H., et al. Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells. J. Biol. Chem. 281 (2006) 18560-18568
26. Miller L.S., et al. TGF-α regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 174 (2005) 6137-6143
27. Kollisch G., et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114 (2005) 531-541
28. Hoover D.M., et al. The structure of human macrophage inflammatory protein-3α /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human β-defensins. J. Biol. Chem. 277 (2002) 37647-37654
29. Niyonsaba F., et al. Human β-defensin-2 functions as a chemotactic agent for tumour necrosis factor-α-treated human neutrophils. Immunology 111 (2004) 273-281
30. Biragyn A., et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298 (2002) 1025-1029
31. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
32. Oppenheim J.J., et al. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62 Suppl 2 (2003) ii17-ii21
33. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75 (2004) 39-48
34. Gombart A.F., et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19 (2005) 1067-1077
35. Agerberth B., et al. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96 (2000) 3086-3093
36. Di Nardo A., et al. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170 (2003) 2274-2278
37. Sorensen O.E., et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97 (2001) 3951-3959
38. Hoover D.M., et al. The structure of human β-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275 (2000) 32911-32918
39. Oren Z., et al. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341 (1999) 501-513
40. Tosi M.F. Innate immune responses to infection. J. Allergy Clin. Immunol. 116 (2005) 241-249
41. Wang T.T., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173 (2004) 2909-2912
42. Crowle A.J., et al. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 55 (1987) 2945-2950
43. Rook G.A.W., et al. Vitamin D3, γ interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57 (1986) 159-163
44. Sly L.M., et al. 1α,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 276 (2001) 35482-35493
45. Anand P.K., and Kaul D. Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages. FEMS Microbiol. Lett. 250 (2005) 137-144
46. Anand P.K., and Kaul D. Vitamin D3-dependent pathway regulates TACO gene transcription. Biochem. Biophys. Res. Commun. 310 (2003) 876-877
47. Alexopoulou L., et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413 (2001) 732-738
48. Heil F., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
49. Schaefer T.M., et al. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J. Immunol. 174 (2005) 992-1002
50. Renn C.N., et al. TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J. Immunol. 177 (2006) 298-305
51. Rivieccio M.A., et al. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J. Immunol. 177 (2006) 4735-4741
52. Hemmi H., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3 (2002) 196-200
53. Horsmans Y., et al. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 42 (2005) 724-731
54. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5 (2006) 471-484
55. Ozato K., et al. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques Suppl. (2002) 66-68 70, 72
56. Lore K., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J. Immunol. 171 (2003) 4320-4328
57. Cooper C.L., et al. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine 22 (2004) 3136-3143
58. Kim J., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169 (2002) 1535-1541
59. Baker B.S., et al. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br. J. Dermatol. 148 (2003) 670-679
60. Krutzik S.R., et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 9 (2003) 525-532
61. Sadeghi K., et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 36 (2006) 361-370
62. Pierik M., et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 12 (2006) 1-8
63. Lee E.Y., et al. Dinucleotide repeat polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to rheumatoid arthritis. Int. J. Immunogenet. 33 (2006) 211-215
64. Mockenhaupt F.P., et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 177-182
65. Schroder N.W., and Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5 (2005) 156-164
66. + T cell response in cancer immunotherapy. J. Gene Med. 7 (2005) 686-695
67. Byrd-Leifer C.A., et al. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur. J. Immunol. 31 (2001) 2448-2457
68. Wang J., et al. MyD88 is involved in the signalling pathway for Taxol-induced apoptosis and TNF-α expression in human myelomonocytic cells. Br. J. Haematol. 118 (2002) 638-645
69. Creticos P.S., et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 355 (2006) 1445-1455
70. Nursyam E.W., et al. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones. 38 (2006) 3-5
71. Dowling G.B., et al. Treatment of Lupus vulgaris with calciferol. Lancet 1 (1947) 919-922